Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer

21 Apr 2017

Abstract excerpt

// Linda Zuurbier 1, * , Arman Rahman 2, * , Martijn Cordes 3 , Jennifer Scheick 4 , Tse J. Wong 4 , François Rustenburg 3 , Jesu Christopher Joseph 2 , Peter Dynoodt 2 , Rory Casey 2 , Paul Drillenburg 5 , Michael Gerhards 5 , Ana Barat 6 , Rut Klinger 7 , Bozena Fender 2 , Darran P. O’Connor 8 , Johannes Betge 9 , Matthias P. Ebert 9 , Timo Gaiser 10 , Jochen H.M. Prehn 6 , Arjan W. Griffioen 4 , Nicole C. T....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apelin-related biomedical research
Share to Cardiovascular, Neuropeptides, and Oxidative Stress Research
Share to Nuclear Receptors and Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28487489
DOI: 10.18632/oncotarget.17306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancerPMID 28487489Read ↗

Biomarkers of Angiogenesis in Colorectal CancerSemantic proximity Read ↗

Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer.Semantic proximity Read ↗

Anti-angiogenesis therapy in cancer: current challenges and future perspectives.Semantic proximity Read ↗

Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.Semantic proximity Read ↗

A biomarker of response to therapy in metastatic BRAFV600E colorectal cancers.Semantic proximity Read ↗

Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension.Semantic proximity Read ↗

Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal CancerSemantic proximity Read ↗

ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone.Semantic proximity Read ↗

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.